[
  {
    "date": "2022-12-30",
    "symbol": "ELDN",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ELDN",
    "entityregistrantname": "ELEDON PHARMACEUTICALS, INC.",
    "entitycentralindexkey": 1404281,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityshellcompany": "true",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "001-36620",
    "entitytaxidentificationnumber": "20-1000967",
    "entityaddressaddressline1": "19900 MacArthur Boulevard",
    "entityaddressaddressline2": "Suite 550",
    "entityaddresscityortown": "Irvine",
    "entityaddressstateorprovince": "California",
    "entityaddresspostalzipcode": 92612,
    "cityareacode": "(949) ",
    "localphonenumber": "238-8090",
    "entityincorporationstatecountrycode": "Delaware",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "security12btitle": "Common Stock, $0.001 par value",
    "securityexchangename": "Nasdaq",
    "auditorfirmid": 170,
    "auditorname": "KMJ Corbin & Company LLP",
    "auditorlocation": "Irvine, California",
    "cashandcashequivalentsatcarryingvalue": 56409000,
    "prepaidexpenseandotherassetscurrent": 3109000,
    "assetscurrent": 59518000,
    "operatingleaserightofuseasset": 739000,
    "inprocessresearchanddevelopment": 32386000,
    "otherassetsnoncurrent": 150000,
    "assets": 92793000,
    "accountspayablecurrent": 2200000,
    "operatingleaseliabilitycurrent": 363000,
    "accruedliabilitiesandotherliabilities": 3912000,
    "liabilitiescurrent": 6475000,
    "deferredincometaxliabilitiesnet": 1752000,
    "operatingleaseliabilitynoncurrent": 383000,
    "liabilities": 8610000,
    "commonstockvalue": 14000,
    "additionalpaidincapitalcommonstock": 287034000,
    "retainedearningsaccumulateddeficit": -202865000,
    "stockholdersequity": -202865000,
    "liabilitiesandstockholdersequity": 92793000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000,
    "preferredstocksharesissued": 6204,
    "preferredstocksharesoutstanding": 6204,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpense": 27080000,
    "generalandadministrativeexpense": 12700000,
    "goodwillimpairmentloss": 48600000,
    "operatingexpenses": 88428000,
    "operatingincomeloss": -88428000,
    "othernonoperatingincomeexpense": 462000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -87966000,
    "netincomeloss": -87966000,
    "earningspersharebasic": -6.16,
    "earningspersharediluted": -6.16,
    "weightedaveragenumberofsharesoutstandingbasic": 509117,
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "sharesoutstanding": "null",
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 20000,
    "cancellationofcommonstockinexchangeforpreferredstockvalue": 1000,
    "cancellationofcommonstockinexchangeforpreferredstockshares": -550000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 8153000,
    "amortizationofoperatingleaseasset": 373000,
    "allocatedsharebasedcompensationexpense": 4923000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -654000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 2081000,
    "increasedecreaseinoperatingleaseliability": -367000,
    "netcashprovidedbyusedinoperatingactivities": -28424000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -28424000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 56409000,
    "increasedecreaseinoperatingleaseassetandliabilityduetoleasemodification": 344000,
    "commonstockexchangedforxonenonvotingconvertiblepreferredstock": 1000,
    "subsidiaryorequitymethodinvesteecumulativepercentageownershipafteralltransactions": 1,
    "cashcashequivalentsandrestrictedcashmaturityperiod": "three months or less",
    "cashequivalentsatcarryingvalue": 9300000,
    "numberofoperatingsegments": 1,
    "numberofreportingunits": 1,
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.001,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedtermsimplifiedmethod": "For stock options granted to the Company’s board of directors (the “Board”), the Company determined the expected life assumption using the simplified method as the starting point with an average period of twelve (12) months added to take into account for the extended range of time of 12 to 18 months vested stock options granted to Board members may be exercised upon termination.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": 18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.5,
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "incometaxexaminationlikelihoodofunfavorablesettlement": "The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.",
    "incometaxexaminationlikelihoodoffavorablesettlement": 0.5,
    "prepaidinsurance": 823000,
    "prepaidclinicalexpense": 2115000,
    "otherprepaidexpensecurrent": 143000,
    "otherassetscurrent": 28000,
    "workerscompensationliabilitycurrent": 1909000,
    "accruedclinicalcurrent": 1826000,
    "accruedprofessionalfeescurrent": 65000,
    "otheraccruedliabilitiescurrent": 112000,
    "operatingleaseexpense": 300000,
    "areaofofficespace": 5197,
    "leaseexpirationdate1": "December 31, 2022",
    "lesseeoperatingleaseremainingtermofcontract": "two years",
    "remainingmilestonepaymentsforfirstlicensedproduct": 6000000,
    "regulatorymilestonepaymentsobligation": 2500000,
    "annuallicensemaintenancefee": 100000,
    "aggregatenetsalesachievement": 1000000000,
    "royaltyguaranteescommitmentsamount": 30000000,
    "operatingleasecost": 403000,
    "operatingleasepayments": 387000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 344000,
    "operatingleaseweightedaverageremainingleaseterm1": 1.95,
    "operatingleaseweightedaveragediscountratepercent": 0.024900000000000002,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 378000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 388000,
    "lesseeoperatingleaseliabilitypaymentsdue": 766000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 20000,
    "operatingleaseliability": 746000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -88159000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 193000,
    "effectivefederalandstateincometaxrate": 0.21,
    "valuationallowancedeferredtaxassetchangeinamount": 9400000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 56800000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 25000000,
    "deferredtaxassetsoperatinglosscarryforwardsforeign": 7900000,
    "netoperatinglosscarryforwardsexpirationperiod": 2035,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 56000000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1200000,
    "taxcreditcarryforwardexpirationperiod": 2030,
    "taxcreditcarryforwardexpirationdescription": "As of December 31, 2022 and 2021, the Company has state research and development credit carryforwards or approximately $1.2 million and $1.1 million, respectively, which will begin expiring in 2030 if not utilized",
    "percentageofcumulativechangeinownership": 0.5,
    "periodforwhichcumulativechangeinownershipannualusenetoperatinglossandresearchanddevelopmentcreditcarryforwards": "three-year",
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -18473000,
    "stateincometaxesnetoffederaltaxbenefits": -2678000,
    "incometaxreconciliationtaxcredits": 1046000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 986000,
    "incometaxreconciliationpermanentitems": 3000,
    "incometaxreconciliationstatetaxratedifferential": 274000,
    "noltrueup": -337000,
    "incometaxreconciliationotheradjustments": 114000,
    "incometaxreconciliationnondeductibleexpenseimpairmentlosses": 11697000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 9460000,
    "deferredtaxassetsoperatinglosscarryforwards": 15230000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 452000,
    "deferredtaxassetsinprocessresearchanddevelopment": 5264000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 2874000,
    "deferredtaxassetsdepreciationandamortization": 1595000,
    "deferredtaxassetsleaseliability": 179000,
    "deferredtaxassetsgross": 27888000,
    "deferredtaxassetsrightofuseasset": 178000,
    "deferredtaxliabilitiesinprocessresearchanddevelopment": 7787000,
    "deferredincometaxliabilities": 7965000,
    "deferredtaxassetsvaluationallowance": 21675000,
    "deferredtaxliabilities": 1752000,
    "unrecognizedtaxbenefits": 2664000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 914000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 281000,
    "convertiblepreferredstocksharesissueduponconversion": "null",
    "classofwarrantorrightoutstanding": 50207.419,
    "equitydistributionagreementmaximumvalueofcommonsharesissuable": 10500000,
    "publicfloatminimumbalancetobemaintained": 75000000,
    "numberofstockcompensationplans": 3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2.45,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 10500000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 263644,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 3.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 12.12,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 8.69,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 8.72,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 8.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": 8.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 7,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.84,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.018000000000000002,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.042,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 15000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 15000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 20000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedandexpectedtovestoutstandingnumber": 15000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaverageexerciseprice": 2.47,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaverageexerciseprice": 2.47,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaverageexerciseprice": 5.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 2.47
  },
  {
    "date": "2021-12-30",
    "symbol": "ELDN",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ELDN",
    "entityregistrantname": "ELEDON PHARMACEUTICALS, INC.",
    "entitycentralindexkey": 1404281,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "001-36620",
    "entitytaxidentificationnumber": "20-1000967",
    "entityaddressaddressline1": "19900 MacArthur Boulevard",
    "entityaddressaddressline2": "Suite 550",
    "entityaddresscityortown": "Irvine",
    "entityaddressstateorprovince": "California",
    "entityaddresspostalzipcode": 92612,
    "cityareacode": "(949) ",
    "localphonenumber": "238-8090",
    "entityincorporationstatecountrycode": "Delaware",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "security12btitle": "Common Stock, $0.001 par value",
    "securityexchangename": "Nasdaq",
    "auditorfirmid": 170,
    "auditorname": "KMJ Corbin & Company LLP",
    "auditorlocation": "Irvine, California",
    "cashandcashequivalentsatcarryingvalue": 84833000,
    "prepaidexpenseandotherassetscurrent": 3513000,
    "assetscurrent": 88346000,
    "operatingleaserightofuseasset": 768000,
    "goodwill": 48648000,
    "inprocessresearchanddevelopment": 32386000,
    "otherassetsnoncurrent": 400000,
    "assets": 170548000,
    "accountspayablecurrent": 1813000,
    "operatingleaseliabilitycurrent": 369000,
    "accruedliabilitiesandotherliabilities": 2219000,
    "liabilitiescurrent": 4401000,
    "deferredincometaxliabilitiesnet": 1752000,
    "operatingleaseliabilitynoncurrent": 400000,
    "liabilities": 6553000,
    "commonstockvalue": 14000,
    "additionalpaidincapitalcommonstock": 278880000,
    "retainedearningsaccumulateddeficit": -114899000,
    "stockholdersequity": -114899000,
    "liabilitiesandstockholdersequity": 170548000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000,
    "preferredstocksharesissued": 6204,
    "preferredstocksharesoutstanding": 6204,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpense": 23735000,
    "generalandadministrativeexpense": 13132000,
    "restructuringcharges": 2300000,
    "operatingexpenses": 36867000,
    "operatingincomeloss": -36867000,
    "othernonoperatingincomeexpense": 7000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -36860000,
    "incometaxexpensebenefit": -2354000,
    "netincomeloss": -34506000,
    "earningspersharebasicanddiluted": -2.33,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "sharesoutstanding": "null",
    "cancellationofcommonstockinexchangeforpreferredstockshares": -344666,
    "cancellationofcommonstockinconnectionwithexchangeforwarrantsvalue": 1000,
    "cancellationofcommonstockinconnectionwithexchangeforwarrantsshares": -509117,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 7904000,
    "stockissuedduringperiodvaluestockoptionsexercised": 1000,
    "stockissuedduringperiodsharesstockoptionsexercised": 174,
    "temporaryequitysharesoutstanding": 108070,
    "amortizationofoperatingleaseasset": 195000,
    "allocatedsharebasedcompensationexpense": 4738000,
    "deferredtaxliability": 2354000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 2095000,
    "increasedecreaseinaccountspayableandaccruedliabilities": 2143000,
    "increasedecreaseinoperatingleaseliability": -200000,
    "netcashprovidedbyusedinoperatingactivities": -28913000,
    "proceedsfromstockoptionsexercised": 1000,
    "paymentsofstockissuancecosts": 450000,
    "netcashprovidedbyusedinfinancingactivities": -449000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -29362000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 84833000,
    "increaseinoperatingleaseassetandliabilityduetolease": 825000,
    "conversionofstockamountissued1": 1000,
    "equitymethodinvestmentownershippercentage": 1,
    "workingcapital": 83900000,
    "convertiblepreferredstocksharesissueduponconversion": "null",
    "stockholdersequityreversestocksplit": "one-for-eighteen",
    "cashcashequivalentsandrestrictedcashmaturityperiod": "three months or less",
    "cashequivalentsatcarryingvalue": 9200000,
    "numberofoperatingsegments": 1,
    "numberofreportingunits": 1,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedtermsimplifiedmethod": "For stock options granted to the Company’s board of directors (the “Board”), the Company determined the expected life assumption using the simplified method as the starting point with an average period of twelve (12) months added to take into account for the extended range of time of 12 to 18 months vested stock options granted to Board members may be exercised upon termination.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": 18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y9M",
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "incometaxexaminationlikelihoodofunfavorablesettlement": "The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.",
    "incometaxexaminationlikelihoodoffavorablesettlement": 0.5,
    "prepaidinsurance": 1344000,
    "prepaidclinicalexpense": 2039000,
    "otherprepaidexpensecurrent": 96000,
    "otherassetscurrent": 34000,
    "workerscompensationliabilitycurrent": 1411000,
    "accruedseverancecurrent": 104000,
    "accruedclinicalcurrent": 454000,
    "accruedprofessionalfeescurrent": 167000,
    "otheraccruedliabilitiescurrent": 83000,
    "goodwillgross": 48648000,
    "operatingleaseexpense": 300000,
    "areaofofficespace": 5197,
    "leaseexpirationdate1": "September 30, 2021",
    "lesseeoperatingleaseremainingtermofcontract": "three years",
    "remainingmilestonepaymentsforfirstlicensedproduct": 6000000,
    "regulatorymilestonepaymentsobligation": 2500000,
    "annuallicensemaintenancefee": 100000,
    "aggregatenetsalesachievement": 1000000000,
    "royaltyguaranteescommitmentsamount": 30000000,
    "operatingleasecost": 283000,
    "operatingleasepayments": 208000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 825000,
    "operatingleaseweightedaverageremainingleaseterm1": 2.41,
    "operatingleaseweightedaveragediscountratepercent": 0.03,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 387000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 212000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 200000,
    "lesseeoperatingleaseliabilitypaymentsdue": 799000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 30000,
    "operatingleaseliability": 769000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -37055000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 195000,
    "deferredfederalincometaxexpensebenefit": -2746000,
    "deferredstateandlocalincometaxexpensebenefit": 392000,
    "deferredincometaxexpensebenefit": -2354000,
    "effectivefederalandstateincometaxrate": 0.21,
    "valuationallowancedeferredtaxassetchangeinamount": 6400000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 46900000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 15000000,
    "deferredtaxassetsoperatinglosscarryforwardsforeign": 7900000,
    "netoperatinglosscarryforwardsexpirationperiod": 2035,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 46100000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 1100000,
    "taxcreditcarryforwardexpirationperiod": 2030,
    "taxcreditcarryforwardexpirationdescription": "As of December 31, 2021 and 2020, the Company has state research and development credit carryforwards or approximately $1.1 million and $0.6 million, respectively, which will begin expiring in 2030 if not utilized",
    "percentageofcumulativechangeinownership": 0.5,
    "periodforwhichcumulativechangeinownershipannualusenetoperatinglossandresearchanddevelopmentcreditcarryforwards": "P3Y",
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -7741000,
    "stateincometaxesnetoffederaltaxbenefits": -445000,
    "incometaxreconciliationtaxcredits": 651000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 651000,
    "incometaxreconciliationpermanentitems": 2000,
    "incometaxreconciliationstatetaxratedifferential": 235000,
    "noltrueup": -991000,
    "incometaxreconciliationotheradjustments": 146000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 6440000,
    "deferredtaxassetsoperatinglosscarryforwards": 12531000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 296000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1867000,
    "deferredtaxassetsdepreciationandamortization": 1713000,
    "deferredtaxassetsleaseliability": 171000,
    "deferredtaxassetsgross": 17934000,
    "deferredtaxassetsrightofuseasset": 171000,
    "deferredtaxliabilitiesinprocessresearchanddevelopment": 7192000,
    "deferredincometaxliabilities": 7363000,
    "deferredtaxassetsvaluationallowance": 12323000,
    "deferredtaxliabilities": 1752000,
    "unrecognizedtaxbenefits": 1469000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 712000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 7000,
    "classofwarrantorrightnumberofwarrantsorrightsissued": 807809,
    "classofwarrantorrightnumberofwarrantsorrightscancelledorexpired": -5376.456,
    "classofwarrantorrightoutstanding": 50207.419,
    "equitydistributionagreementmaximumvalueofcommonsharesissuable": 75000000,
    "numberofstockcompensationplans": 3,
    "stockholdersequitynotestocksplitconversionratio1": 0.05555555555,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2147,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 15900000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 702836,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 110164,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 10.69,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 4.73,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 19.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 10.18,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 11.64,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 1.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 1.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 20000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 20000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedandexpectedtovestoutstandingnumber": 20000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaverageexerciseprice": 5.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaverageexerciseprice": 5.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 5.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsoutstandingweightedaverageremainingcontractualterms": "P9Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantedoutstandingweightedaverageremainingcontractualterm": "P9Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm": "P9Y9M18D"
  },
  {
    "date": "2020-12-30",
    "symbol": "ELDN",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ELDN",
    "entityregistrantname": "ELEDON PHARMACEUTICALS, INC.",
    "entitycentralindexkey": 1404281,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "001-36620",
    "entitytaxidentificationnumber": "20-1000967",
    "entityaddressaddressline1": "19900 MacArthur Boulevard",
    "entityaddressaddressline2": "Suite 550",
    "entityaddresscityortown": "Irvine",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92612,
    "cityareacode": "(949)",
    "localphonenumber": "238-8090",
    "entityincorporationstatecountrycode": "DE",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "icfrauditorattestationflag": "false",
    "security12btitle": "Common Stock, $0.001 par value",
    "securityexchangename": "NASDAQ",
    "cashandcashequivalentsatcarryingvalue": 114195000,
    "prepaidexpenseandotherassetscurrent": 1435000,
    "assetscurrent": 115630000,
    "operatingleaserightofuseasset": 138000,
    "goodwill": 48648000,
    "inprocessresearchanddevelopment": 32386000,
    "otherassetsnoncurrent": 383000,
    "assets": 197185000,
    "accountspayablecurrent": 1366000,
    "operatingleaseliabilitycurrent": 144000,
    "accruedseverancecurrent": 12000,
    "accruedliabilitiesandotherliabilities": 961000,
    "liabilitiescurrent": 2483000,
    "deferredincometaxliabilitiesnet": 4106000,
    "liabilities": 6589000,
    "commonstockvalue": 15000,
    "additionalpaidincapitalcommonstock": 270974000,
    "retainedearningsaccumulateddeficit": -80393000,
    "stockholdersequity": -80393000,
    "liabilitiesandstockholdersequity": 197185000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 10000,
    "preferredstocksharesissued": 108070,
    "preferredstocksharesoutstanding": 6203.98,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 200000000,
    "commonstocksharesissued": 15160397,
    "commonstocksharesoutstanding": 14306614,
    "researchanddevelopmentexpense": 6131000,
    "generalandadministrativeexpense": 10052000,
    "restructuringcharges": 2282000,
    "operatingexpenses": 18465000,
    "operatingincomeloss": -18465000,
    "othernonoperatingincomeexpense": 79000,
    "warrantinducementexpense": 4829000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -23215000,
    "incometaxexpensebenefit": -404000,
    "netincomeloss": -22811000,
    "earningspersharebasicanddiluted": -15.72,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 1451432,
    "temporaryequitysharesoutstanding": 108070,
    "sharesoutstanding": 15160397,
    "stockissuedduringperiodvaluenewissues": 8550000,
    "stockissuedduringperiodsharesnewissues": 1004111,
    "stockissuedduringperiodvaluewarrantsexercised": 5380000,
    "stockissuedduringperiodshareswarrantsexercised": 28553,
    "stockissuedduringperiodvalueconversionofconvertiblesecurities": -13000,
    "stockissuedduringperiodsharesconversionofconvertiblesecurities": 12837056,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 3059,
    "stockissuedduringperiodvalueacquisitions": 1194000,
    "stockissuedduringperiodsharesacquisitions": 175488,
    "cancellationofcommonstockinexchangeforpreferredstockshares": -210889,
    "cancellationofcommonstockinconnectionwithreversesplitvalue": -25000,
    "cancellationofcommonstockinconnectionwithreversesplitshares": -1493,
    "temporaryequitystockissuedduringperiodvalueacquisitions": 69723000,
    "temporaryequitystockissuedduringperiodsharesacquisitions": 140026,
    "temporaryequitystockissuedduringperiodvaluenewissues": 95226000,
    "temporaryequitystockissuedduringperiodsharesnewissues": 199112,
    "adjustmentstoadditionalpaidincapitalfairvalueofoptionsassumedinacquisition": 2950000,
    "adjustmentstoadditionalpaidincapitalfairvalueofwarrantsassumedinacquisition": 12944000,
    "warrantsissuedduringperiodinducementexpense": 4829000,
    "stockissuedduringperiodvaluerestrictedstockawardnetofforfeitures": 205000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 3171000,
    "depreciationandamortization": 5000,
    "amortizationofoperatingleaseasset": 178000,
    "allocatedsharebasedcompensationexpense": 1917000,
    "deferredtaxliability": 404000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -39000,
    "increasedecreaseinaccountspayableandaccruedliabilities": -39000,
    "increasedecreaseinoperatingleaseliability": -180000,
    "netcashprovidedbyusedinoperatingactivities": -15212000,
    "cashacquiredfromacquisition": 11035000,
    "netcashprovidedbyusedininvestingactivities": 11035000,
    "proceedsfromissuanceofcommonstock": 9000000,
    "proceedsfromissuanceofpreferredstockandpreferencestock": 95226000,
    "proceedsfromwarrantexercises": 5380000,
    "cashpaidforcancellationofcommonstockinconnectionwithreversesplit": 25000,
    "netcashprovidedbyusedinfinancingactivities": 109581000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 105404000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 114195000,
    "conversionofseriesx1preferredstockintocommonstock": 13000,
    "issuanceofcommonstockinacquisition": 1194000,
    "issuanceofnonvotingconvertiblepreferredstockinacquisition": 69723000,
    "fairvalueofoptionsassumedinacquisition": 2950000,
    "fairvalueofwarrantsassumedinacquisition": 12944000,
    "accruedofferingcosts": 450000,
    "equitymethodinvestmentownershippercentage": 1,
    "workingcapital": 113100000,
    "convertiblepreferredstocksharesissueduponconversion": 344663,
    "stockholdersequityreversestocksplit": "one-for-eighteen",
    "cashcashequivalentsandrestrictedcashmaturityperiod": "three months or less",
    "cashequivalentsatcarryingvalue": 9200000,
    "numberofoperatingsegments": 1,
    "numberofreportingunits": 1,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 3959302,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedtermsimplifiedmethod": "For stock options granted to the board of directors, the Company determined the expected life assumption using the simplified method as the starting point with an average period of twelve (12) months added to take into account for the extended range of time of 12 to 18 months vested stock options granted to board of directors may be exercised upon termination.",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P18M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "commonstockcapitalsharesreservedforfutureissuance": 4860000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "incometaxexaminationlikelihoodofunfavorablesettlement": "The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement.",
    "incometaxexaminationlikelihoodoffavorablesettlement": 0.5,
    "prepaidinsurance": 1157000,
    "prepaidclinicalexpense": 89000,
    "otherprepaidexpensecurrent": 41000,
    "insurancesettlementsreceivablecurrent": 110000,
    "otherassetscurrent": 38000,
    "workerscompensationliabilitycurrent": 31000,
    "accruedclinicalcurrent": 258000,
    "accruedprofessionalfeescurrent": 9000,
    "accruedvacationcurrent": 67000,
    "accruedfinancingcosts": 450000,
    "otheraccruedliabilitiescurrent": 146000,
    "goodwillgross": 48648000,
    "goodwillacquiredduringperiod": 48648000,
    "leaseandrentalexpense": 207000,
    "areaofofficespace": 5197,
    "leaseexpirationdate1": "2021-06-30",
    "numberofofficespacesoperatinglease": 4,
    "lesseeoperatingleaseremainingtermofcontract": "P1Y",
    "lesseeshorttermoperatingleaseliabilitypaymentsduenexttwelvemonths": 33000,
    "remainingmilestonepaymentsforfirstlicensedproduct": 6000000,
    "regulatorymilestonepaymentsobligation": 2500000,
    "annuallicensemaintenancefee": 100000,
    "aggregatenetsalesachievement": 1000000000,
    "royaltyguaranteescommitmentsamount": 30000000,
    "operatingleasecost": 195000,
    "operatingleasepayments": 188000,
    "operatingleaseweightedaverageremainingleaseterm1": "P9M",
    "operatingleaseweightedaveragediscountratepercent": 0.0325,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 146000,
    "lesseeoperatingleaseliabilitypaymentsdue": 146000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 2000,
    "operatingleaseliability": 144000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -23408000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": 193000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -23215000,
    "deferredfederalincometaxexpensebenefit": -404000,
    "deferredincometaxexpensebenefit": -404000,
    "effectiveincometaxratecontinuingoperations": 0.23,
    "effectivefederalandstateincometaxrate": 0.21,
    "valuationallowancedeferredtaxassetchangeinamount": -5100000,
    "deferredtaxassetsoperatinglosscarryforwardsdomestic": 14400000,
    "deferredtaxassetsoperatinglosscarryforwardsstateandlocal": 6200000,
    "deferredtaxassetsoperatinglosscarryforwardsforeign": 7900000,
    "netoperatinglosscarryforwardsexpirationperiod": 2035,
    "deferredtaxassetsoperatinglosscarryforwardsnotsubjecttoexpiration": 13600000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 562000,
    "taxcreditcarryforwardexpirationperiod": 2030,
    "taxcreditcarryforwardexpirationdescription": "As of December 31, 2020 and 2019, the Company has state research and development credit carryforwards or approximately $562,000 and $264,000, respectively, which will begin expiring in 2030 if not utilized.",
    "percentageofcumulativechangeinownership": 0.5,
    "periodforwhichcumulativechangeinownershipannualusenetoperatinglossandresearchanddevelopmentcreditcarryforwards": "P3Y",
    "effectiveincometaxratereconciliationsectionthreehundredandeightytwolimitationonnetoperatinglossesandcredits": 10562000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -4875000,
    "incometaxreconciliationtaxcredits": 215000,
    "effectiveincometaxratereconciliationchangeinwarrantfairmarketvalueamount": 1014000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 252000,
    "incometaxreconciliationpermanentitems": 627000,
    "incometaxreconciliationotheradjustments": 89000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": -7858000,
    "deferredtaxassetsoperatinglosscarryforwards": 5151000,
    "deferredtaxassetstaxdeferredexpensereservesandaccruals": 14000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 802000,
    "deferredtaxassetsdepreciationandamortization": 1905000,
    "deferredtaxassetsleaseliability": 30000,
    "deferredtaxassetsgross": 8607000,
    "deferredtaxassetsrightofuseasset": 29000,
    "deferredtaxliabilitiesinprocessresearchanddevelopment": 6801000,
    "deferredincometaxliabilities": 6830000,
    "deferredtaxassetsvaluationallowance": 5883000,
    "deferredtaxliabilities": 4106000,
    "unrecognizedtaxbenefits": 764000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 233000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 531000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 548000,
    "commonstockvalueofsharesissuable": 188773,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 509117,
    "classofwarrantorrightnumberofwarrantsorrightsexercised": 457390,
    "classofwarrantorrightoutstanding": 55583.875,
    "classofwarrantorrightnumberofwarrantsorrightsassumedandreplaced": 55583.875,
    "conversionofstocksharesconverted1": 344666,
    "conversionofstocksharesissued1": 6203.98,
    "classofwarrantorrightnumberofwarrantsorrightsissued": 402397,
    "numberofstockcompensationplans": 3,
    "stockholdersequitynotestocksplitconversionratio1": 0.05555555555,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 3621479,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 4167044,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 2147,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 17100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2191462,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsinconnectionwithacquisition": 1346398,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiod": 7784,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 3621479,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 878033,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 9.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsinconnectionwithacquisitionweightedaverageexerciseprice": 7.58,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresandexpirationsinperiodweightedaverageexerciseprice": 586.16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 15.21,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 16,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P8Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P8Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 23938701000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 23938701000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 6297510000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 3056,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaverageexerciseprice": 66.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 1.07,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.01,
    "restructuringreserve": 12000,
    "paymentsforrestructuring": 2270000,
    "businesscombinationacquisitionrelatedcosts": 3400000,
    "gainslossesonextinguishmentofdebt": 655000,
    "othergeneralexpense": 512000,
    "businessacquisitionproformanetincomelossandothercomprehensiveincomeloss": -24314000,
    "businessacquisitionsproformarevenue": 120000,
    "businessacquisitionsproformaresearchanddevelopmentexpense": 9489000,
    "businessacquisitionproformageneralandadministrativeexpense": 8317000,
    "businessacquisitionsproformarestructuringexpense": 2282000,
    "businessacquisitionproformaoperatingexpenses": 20088000,
    "businessacquisitionproformaoperatingincomeloss": -19968000,
    "businessacquisitionproformaothernonoperatingincomeexpense": 79000,
    "businessacquisitionproformawarrantinducementexpense": 4829000,
    "businessacquisitionproformaincomelossbeforeprovisionforincometaxes": -24718000,
    "businessacquisitionproformaincometaxexpensebenefit": -404000,
    "businessacquisitionproformaearningspersharebasicanddiluted": -15.44,
    "businessacquisitionproformaweightedaveragenumberofsharesoutstandingbasicanddiluted": 1574657
  }
]